JASPREET TAKHAR: Open Payments
NPI 1285347526 · WOODBRIDGE, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,384 in 58 payments from 10 companies in 2025. Trend: 2023 $27 · 2024 $404 · 2025 $1,384
Food & beverage: $1,384
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 13 | $460 |
| Novartis Pharmaceuticals Corporation | 13 | $293 |
| GlaxoSmithKline, LLC. | 13 | $191 |
| Amgen Inc. | 4 | $93 |
| ARS Pharmaceuticals Operations, Inc. | 4 | $87 |
| Regeneron Healthcare Solutions, Inc. | 3 | $77 |
| Greer Laboratories, Inc. | 3 | $74 |
| CSL Behring | 2 | $48 |
| Ionis Pharmaceuticals, Inc. | 2 | $44 |
| Optinose US, Inc. | 1 | $17 |
Products named: TEZSPIRE, BREZTRI, NUCALA, FASENRA, AIRSUPRA, NEFFY, Rhapsido, DUPIXENT.
Industry payments across VA — which companies pay providers there.
